Yalonda is a litigator and relationship partner whose focus is on the life sciences industry. Yalonda frequently assembles cross-functional teams to meet her clients’ needs and has successfully fostered a collaborative approach to counsel several publicly traded and early-stage life sciences and biotechnology companies on an array of matters. Yalonda and her team also specialize in conducting comprehensive product risk and compliance assessments for clients, and she is national counsel in product liability cases for publicly traded life sciences companies.
Yalonda specializes in complex tort and product liability litigation.
Yalonda currently serves as national counsel in product liability litigation for two publically traded companies and advises with respect to potential commercial and product liability litigation relating to various products, including biologic therapies and assay development. Yalonda also has expertise in alternative billing models, budgeting, and efficient case management of complex cases. She has represented clients in state and federal courts and appeared pro hac in many states. She is a member of the Supreme Judicial Court of Massachusetts, the Massachusetts Appeals Court, the United States District Court, and United States Court of Appeals for the First, Second and Third Circuit. Yalonda is a member of bar of the Supreme Court of the United States.
Yalonda also served on a number of Mintz's internal committees, including the firm’s Hiring Committee and its Diversity Committee. She is also director of Mintz’s pro bono initiative in conjunction with the Dana-Farber Cancer Institute.
- University of Virginia (JD)
- Harvard University (MDiv)
- University of Michigan (BA)
- Currently national counsel representing a U.S.-based publicly traded biotechnology company in multi-jurisdictional product liability disputes involving FDA-approved pharmaceutical drugs and assay test development.
- Represented a pharmaceutical company in wrongful death and personal injury actions involving participants in phase III clinical trials.
- Represented a pharmaceutical company in a wrongful death action brought by the estate of a person who died while participating in a company-sponsored phase III clinical trial.
- Currently representing a European-based publicly traded pharmaceutical company as coordinating counsel in multi-jurisdictional product liability disputes involving an FDA-regulated pharmaceutical drug.
- Advised a sample and diagnostic testing manufacturer regarding claims related to diagnostic testing and product recall issues, successfully avoiding litigation.
- Represented a medical device manufacturer in a claim brought by the estate of a patient who died while allegedly using the manufacturer’s medical device.
- Represented a medical device manufacturer in multi-jurisdictional medical device litigation involving more than 250 individual claims.
Recognition & Awards
- Awarded the Ida B. Wells pioneer award by the Massachusetts Black Women Attorneys Association (2016)
- Massachusetts Super Lawyers: Rising Star – Personal Injury Defense: Products (2012-2014)
- Massachusetts Supreme Judicial Court Adams Pro Bono Award (2011)
- Massachusetts Lawyers Weekly: “25 Rising Stars of the Bar” (2008)
- Greater Boston Chamber of Commerce: Boston's Future Leaders (2011)
- Women’s Leadership Initiative Participant, Women’s Bar Association of Massachusetts (2011 – 2012)
- Member, Boston Bar Association
- Member, American Bar Association
- Board member, Lawyers’ Committee for Civil Rights